Literature DB >> 11172307

Synchronous pulmonary adenocarcinoma and extranodal marginal zone/low-grade B-cell lymphoma of MALT type.

S Chanel1, L Burke, M Fiche, T Molina, J P Lerochais, P Icard, J Diebold, F Galateau-Sallé.   

Abstract

A case of synchronous adenocarcinoma of lung and extranodal marginal zone/low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) is reported. Primary pulmonary non-Hodgkin's lymphoma is relatively rare, however, the majority of these lesions are low-grade B-cell lymphomas of MALT. After the stomach, the lung is the second most common location for such latter lesions. Lung adenocarcinoma in selected countries is fast becoming the leading form of non small-cell lung carcinoma. To our knowledge, this synchronous occurrence in the lung has not been previously reported. Such associations have been primarily limited to gastric lesions where an association with Helicobacter pylori infection has been identified. This case report highlights the importance of adjunctive diagnostic investigations such as molecular techniques in conclusive analysis of synchronous cases such as ours.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172307     DOI: 10.1053/hupa.2001.20893

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  A tale of synchronous lung carcinoma and diffuse large B-cell lymphoma of ileum: A rare combination.

Authors:  Daphne Fonseca; Bharati Musthyala; Faiq Ahmed; Sudha S Murthy; K V V N Raju
Journal:  Lung India       Date:  2015 Jul-Aug

2.  Mixed large cell neuroendocrine carcinoma and mucosa-associated lymphoid tissue lymphoma of the lung: A case report.

Authors:  Takeshi Matsumoto; Yukihiro Imai; Yasuhiro Kosaka; Takashi Shintani; Keisuke Tomii
Journal:  Oncol Lett       Date:  2015-02-27       Impact factor: 2.967

3.  A Case of Synchronous Lung Adenocarcinoma and Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type.

Authors:  Chi Young Jung; Kun Young Kwon
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-07-31

4.  Lung cancer and concurrent or sequential lymphoma: Two case reports with hypersensitivity to bevacizumab and a review of the literature.

Authors:  Aldo Pezzuto; Alessio Piraino; Salvatore Mariotta
Journal:  Oncol Lett       Date:  2014-11-20       Impact factor: 2.967

5.  Synchronous pulmonary squamous cell carcinoma and mantle cell lymphoma of the lymph node.

Authors:  Yu Sun; Yun-Fei Shi; Li-Xin Zhou; Ke-Neng Chen; Xiang-Hong Li
Journal:  Case Rep Genet       Date:  2011-07-02

6.  Synchronous BALT Lymphoma and Squamous Cell Carcinoma of the Lung: Coincidence or Linkage?

Authors:  Anastasia Oikonomou; Emanuelle Astrinakis; Ioannis Kotsianidis; Vassiliki Kaloutsi; Vassileios Didilis; Konstantinos Tsatalas; Panos Prassopoulos
Journal:  Case Rep Oncol Med       Date:  2013-02-28

7.  A rare tumoral combination, synchronous lung adenocarcinoma and mantle cell lymphoma of the pleura.

Authors:  Dimitrios Hatzibougias; Mattheos Bobos; Georgia Karayannopoulou; Georgios Karkavelas; Georgios T Karapanagiotidis; Christophoros N Foroulis; Ioannis Kostopoulos
Journal:  World J Surg Oncol       Date:  2008-12-29       Impact factor: 2.754

8.  Synchronous diffuse large B-cell lymphoma of the stomach and small cell lung carcinoma: A case report.

Authors:  Jia Li; Changli Zhou; Wanqi Liu; Xun Sun; Xiangwei Meng
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 9.  Synchronous primary pulmonary adenocarcinoma and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: A case report and literature review.

Authors:  Lixia Sun; Bing Zhang; Ke Xuan; Li Qi; Jingjing Wang; Quan Li; Jianwei Liu; Yubo Wang; Liping Sun; Xiaomei Li; Hong Ji
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

10.  One Pulmonary Lesion, 2 Synchronous Malignancies.

Authors:  Masooma Aqeel; Nevin Uysal-Biggs; Timothy S Fenske; Nagarjun Rao
Journal:  J Investig Med High Impact Case Rep       Date:  2018-06-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.